Home
Discover
Research
Finance
Strategy

Get 40% off Premium. Unlock the BEST of AlphaPilot.

Finance
NKGN

Overview Financials Analysis Smart Money

NKGen Biotech, Inc. Common Stock

NKGN · NASDAQ

Analyze with AI

Filings1

Total reported value$102.0K

Manager	Shares	Value	Change
METEORA CAPITAL, LLC	2.8M	$102.0K	+50.0%

SymbolNKGN

Market Cap$4.6M

IPO Date2023-10-02

CEOPaul Y. Song

Employees63

SectorHealthcare

IndustryBiotechnology

CountryUS

ExchangeNASDAQ

Aimei Health Technology Co., Ltd

AFJK

$52.23

+100.81%

Athira Pharma, Inc.

ATHA

$6.72

+62.52%

Sable Offshore Corp.

SOC

$8.25

+56.25%

Zeta Network Group

ZNB

$1.02

+55.73%

Vivakor, Inc.

VIVK

$0.0751

+47.25%

Peers

Windtree Therapeutics, Inc.

WINT · NASDAQ

$0.04

+5.26%

PMGC Holdings Inc.

ELAB · NASDAQ

$2.18

-5.63%

BriaCell Therapeutics Corp. Warrant

BCTXZ · NASDAQ

$0.39

+14.71%

Protagenic Therapeutics, Inc.

PTIX · NASDAQ

$1.29

-5.84%

XORTX Therapeutics Inc.

XRTX · NASDAQ

$0.5906

+0.96%

Moolec Science S.A.

MLEC · NASDAQ

$0.334

+2.61%

Virax Biolabs Group Limited

VRAX · NASDAQ

$0.386

-4.34%

Dermata Therapeutics, Inc.

DRMA · NASDAQ

$2.18

-5.22%

NewcelX Ltd.

NCEL · NASDAQ

$2.65

-0.75%

Avenue Therapeutics, Inc.

ATXI · NASDAQ

$0.6519

+0.02%

Home

Home
Research
Strategy
Signal
Discover

Education

Academy
Tutorial
Strategy
Agent
Finance

Resources

Pricing
Referral
Partners
FAQ

Other

Terms
Privacy

Disclaimer: Content on AlphaPilot is for informational purposes only and does not constitute financial or investment advice. Past performance, including backtested results, is not indicative of future outcomes. AlphaPilot makes no guarantees regarding accuracy or reliability; use at your own risk.